Galera Therapeutics, Inc. — All Filings
325 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-Q
144
25-NSE
3
4
4/A
424B4
424B5
425
5
8-A12B
8-K
8-K/A
ARS
CERT
CORRESP
D
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
NT 10-Q
PRE 14A
S-1
S-1/A
S-3
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13G
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 4 | FORM 4 SUBMISSION | 0000899243-23-006473 | Feb 28, 2023 | Feb 25, 2023 |
| 4 | FORM 4 SUBMISSION | 0000899243-23-006469 | Feb 28, 2023 | Feb 25, 2023 |
| 4 | FORM 4 SUBMISSION | 0000899243-23-006475 | Feb 28, 2023 | Feb 25, 2023 |
| SC 13G | — | 0001193805-23-000248 | Feb 28, 2023 | — |
| 4 | FORM 4 SUBMISSION | 0000899243-23-006467 | Feb 28, 2023 | Feb 25, 2023 |
| 4 | FORM 4 SUBMISSION | 0000899243-23-006468 | Feb 28, 2023 | Feb 25, 2023 |
| 4 | FORM 4 SUBMISSION | 0000899243-23-006470 | Feb 28, 2023 | Feb 25, 2023 |
| 424B5 | 424B5 | 0001193125-23-040353 | Feb 16, 2023 | — |
| 8-K | 8-K | 0001193125-23-041168 | Feb 16, 2023 | Feb 15, 2023 |
| 8-K | 8-K | 0001193125-23-039798 | Feb 15, 2023 | — |
| SC 13G | SC 13G | 0001104659-23-019589 | Feb 13, 2023 | — |
| SC 13D | SC 13D | 0001193125-23-030224 | Feb 9, 2023 | — |
| SC 13D/A | SC 13D/A | 0001104659-23-010750 | Feb 6, 2023 | — |
| 8-K | 8-K | 0001193125-23-015157 | Jan 25, 2023 | Jan 24, 2023 |
| 8-K | 8-K | 0001193125-22-302295 | Dec 12, 2022 | — |
| 8-K | 8-K | 0001193125-22-301791 | Dec 9, 2022 | Dec 6, 2022 |
| 4 | FORM 4 SUBMISSION | 0000899243-22-036697 | Nov 22, 2022 | Nov 21, 2022 |
| 8-K | 8-K | 0001193125-22-280669 | Nov 9, 2022 | — |
| 10-Q | 10-Q | 0000950170-22-023516 | Nov 9, 2022 | Sep 30, 2022 |
| 8-K | 8-K | 0001193125-22-269333 | Oct 26, 2022 | — |
| 4 | FORM 4 SUBMISSION | 0000899243-22-030911 | Sep 13, 2022 | Sep 12, 2022 |
| 3 | FORM 3 SUBMISSION | 0000899243-22-030281 | Sep 2, 2022 | Sep 1, 2022 |
| 4 | FORM 4 SUBMISSION | 0000899243-22-030285 | Sep 2, 2022 | Sep 1, 2022 |
| 8-K | 8-K | 0001193125-22-215574 | Aug 9, 2022 | — |
| 10-Q | 10-Q | 0000950170-22-015753 | Aug 9, 2022 | Jun 30, 2022 |
| 4 | FORM 4 SUBMISSION | 0000899243-22-026391 | Jul 20, 2022 | Jul 18, 2022 |
| 4 | FORM 4 SUBMISSION | 0000899243-22-024971 | Jul 5, 2022 | Jul 1, 2022 |
| 8-K | 8-K | 0001193125-22-175514 | Jun 16, 2022 | Jun 15, 2022 |
| 4 | FORM 4 SUBMISSION | 0000899243-22-022798 | Jun 16, 2022 | Jun 15, 2022 |
| 4 | FORM 4 SUBMISSION | 0000899243-22-022786 | Jun 16, 2022 | Jun 15, 2022 |
| 4 | FORM 4 SUBMISSION | 0000899243-22-022787 | Jun 16, 2022 | Jun 15, 2022 |
| 4 | FORM 4 SUBMISSION | 0000899243-22-022790 | Jun 16, 2022 | Jun 15, 2022 |
| 4 | FORM 4 SUBMISSION | 0000899243-22-022793 | Jun 16, 2022 | Jun 15, 2022 |
| 8-K | 8-K | 0001193125-22-171970 | Jun 10, 2022 | Jun 8, 2022 |
| 10-Q | 10-Q | 0000950170-22-009950 | May 16, 2022 | Mar 31, 2022 |
| 8-K | 8-K | 0001193125-22-150894 | May 16, 2022 | — |
| DEF 14A | DEF 14A | 0001193125-22-125368 | Apr 28, 2022 | Jun 15, 2022 |
| DEFA14A | DEFA14A | 0001193125-22-125392 | Apr 28, 2022 | — |
| 8-K | 8-K | 0001193125-22-071251 | Mar 10, 2022 | — |
| 10-K | 10-K | 0000950170-22-003292 | Mar 10, 2022 | Dec 31, 2021 |
| 4 | FORM 4 SUBMISSION | 0000899243-22-008583 | Mar 2, 2022 | Feb 28, 2022 |
| 4 | FORM 4 SUBMISSION | 0000899243-22-008581 | Mar 2, 2022 | Feb 28, 2022 |
| 4 | FORM 4 SUBMISSION | 0000899243-22-008582 | Mar 2, 2022 | Feb 28, 2022 |
| 4 | FORM 4 SUBMISSION | 0000899243-22-008578 | Mar 2, 2022 | Feb 28, 2022 |
| 4 | FORM 4 SUBMISSION | 0000899243-22-008580 | Mar 2, 2022 | Feb 28, 2022 |
| 4 | FORM 4 SUBMISSION | 0000899243-22-008585 | Mar 2, 2022 | Feb 28, 2022 |
| SC 13G/A | GALERA THERAPEUTICS, INC. | 0001104659-22-021334 | Feb 14, 2022 | — |
| SC 13G/A | SC 13G/A | 0001193125-22-035528 | Feb 11, 2022 | — |
| SC 13G/A | SC 13G/A | 0001104659-22-020559 | Feb 11, 2022 | — |
| SC 13G | SC 13G | 0001019056-22-000175 | Feb 11, 2022 | — |